V031-0469 Screening compound: N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide

V031-0469 Screening compound: N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide
V031-0469 Screening compound: N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V031-0469
N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V031-0469

Molecular Formula

C23H30N2O4 (C23 H30 N2 O4)

Compound Name

N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide

IUPAC name

N-[(furan-2-yl)methyl]-2-[1-(4-methylphenyl)-N-propylformamido]-N-[(oxolan-2-yl)methyl]acetamide

SMILES

CCCN(CC(N(CC1OCCC1)Cc1ccco1)=O)C(c1ccc(C)cc1)=O

InChI

InChI=1S/C23H30N2O4/c1-3-12-24(23(27)19-10-8-18(2)9-11-19)17-22(26)25(15-20-6-4-13-28-20)16-21-7-5-14-29-21/h4,6,8-11,13,21H,3,5,7,12,14-17H2,1-2H3/t21-/m1/s1

InChI Key

REEUUIZXHVZPJB-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD19740573

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

398.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.850

Distribution Coefficient, logD

2.850

Water Solubility, LogSw

-2.85

Polar Surface Area

48.515

Acid Dissociation Constant (pKa)

22.43

Base Dissociation Constant (pKb)

-1.11

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.80

V031-0469 in Drug Discovery

Included in Screening Libraries

CNS MPO Library (28609 compounds)

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V031-0469 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V031-0469?
Check Price and Availability of V031-0469, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V031-0469 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V031-0469
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V031-0469
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V031-0469 available by request